Publication | Closed Access

Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells

ImmunologyImmune Checkpoint InhibitorAutoimmunityB-lymphoid Tumor CellsAntibody EngineeringImmunotherapyMedicineCell BiologyTumor Biology